Merus N.V. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$6.19 | $223.86 M | -2.51 | 58 | $0 |
ADAG
Adagene Inc. |
$2.00 | $131.46 M | -6.77 | 174 | $18.11 M |
ANAB
AnaptysBio, Inc. |
$13.36 | $640.07 M | -3.82 | 117 | $17.16 M |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.69 | $56.28 M | -5.86 | 2 | $0 |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$52.03 | $3.53 B | -11.86 | 290 | $4.01 M |
INBX
Inhibrx Biosciences, Inc. |
$15.20 | $241.02 M | -1.44 | 166 | $1.80 M |
KRON
Kronos Bio, Inc. |
$0.97 | $44.62 M | -0.37 | 58 | $6.29 M |
KURA
Kura Oncology, Inc. |
$8.80 | $1.66 B | -10.03 | 142 | $0 |
LRMR
Larimar Therapeutics, Inc. |
$4.03 | $611.84 M | -9.99 | 42 | $0 |
LYEL
Lyell Immunopharma, Inc. |
$0.66 | $619.50 M | -2.7 | 224 | $130,000 |
MLYS
Mineralys Therapeutics, Inc. |
$12.45 | $652.38 M | -6.03 | 28 | $0 |
PCVX
Vaxcyte, Inc. |
$84.43 | $7.72 B | -16.54 | 254 | $0 |
PTGX
Protagonist Therapeutics, Inc. |
$39.17 | $2.04 B | 13.7 | 126 | $60.00 M |
REPL
Replimune Group, Inc. |
$13.26 | $485.18 M | -2.44 | 331 | $0 |
SNDX
Syndax Pharmaceuticals, Inc. |
$13.98 | $1.66 B | -6.02 | 184 | $0 |
STRO
Sutro Biopharma, Inc. |
$2.04 | $303.46 M | -1.97 | 302 | $153.73 M |